Evan Lind

5.8k citations
36 papers · 3.3k · 2 hit papers · h-index 20

Impact in

  • Immunology top 1%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Mast cells and histamine
    • IL-33, ST2, and ILC Pathways
    • Immune Response and Inflammation
  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Immune Cell Function and Interaction 13
    • Immunotherapy and Immune Responses 10
    • Immune cells in cancer 6
    • T-cell and B-cell Immunology 5
    • Immune Response and Inflammation 5
    • CAR-T cell therapy research 11

Evan Lind

35 papers receiving 3.2k citations

Evan Lind's Hit Papers

Mast cells are essential intermediaries in regulatory T-cell tolerance 2006 · 595 citations
5950+7+14Years since publication100200300400500

Peers

Evan Lind
Comparison fields: 5 of 103
  • Immunology 1.9k
  • Hematology 369
  • Immunology and Allergy 179
  • Cell Biology 463
  • Oncology 538
Replace Roberta Pelanda with:
Roberta Pelanda United States
Mary J. Janatpour United States
Byoung S. Kwon South Korea
Caren Furlonger Canada
Michel Ticchioni France
Theresa T. Lu United States
Susan Schlenner Belgium
Sarah E. Bell United Kingdom
Dhavalkumar D. Patel United States
Laurent Bartholin France
Evan Lind relative to Roberta Pelanda United States Roberta Pelanda's profile →
Citations per field
00.5×3.2×
Roberta Pelanda · 1×
Citations per year

Countries citing papers authored by Evan Lind

Since Specialization
Citations

This map shows the geographic impact of Evan Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Lind more than expected).

Fields of papers citing papers by Evan Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Lind. The network helps show where Evan Lind may publish in the future.

Co-authors

The 25 scholars most cited alongside Evan Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Evan Lind Line = papers co-authored together Evan Lind links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mast cells are essential intermediaries in regulatory T-cell tolerance
Hit paper breakdown →
2006595
2
CD40/CD154 Interactions at the Interface of Tolerance and Immunity
Hit paper breakdown →
2004517
3 2002453
4 2001289
5 2009283
6
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
1986121
7 2002116
8 201896
9 201295
10 201193
11 201887
12 200677
13 201367
14 200853
15 201544
16 199943
17 201038
18 202031
19 201230
20 200722

About Evan Lind

Evan Lind is a scholar working on Immunology, Oncology, Molecular Biology, Hematology and Cancer Research, having authored 36 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (6 papers), Acute Myeloid Leukemia Research (6 papers), T-cell and B-cell Immunology (5 papers), Immune Response and Inflammation (5 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Immunology (1.9k citations), Hematology (369 citations), Immunology and Allergy (179 citations), Cell Biology (463 citations) and Oncology (538 citations). Evan Lind has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Randolph J. Noelle, Lamis Z. Jarvinen, Sergio A. Quezada, Pamela S. Ohashi, Howard T. Petrie, Susan E. Prockop, Adam J. Lamble, Kathy A. Bennett, Marella de Bruijn and Laleh Talebian. Their work appears in journals such as Blood, The Journal of Immunology, Leukemia, The Journal of Experimental Medicine and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact